Correction to “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”

Abstract

This is a correction to the published paper titled “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”. Figure 2 is incorrect as it appears in the published version. This correction is requested to ensure the accuracy of the information presented in the article.

Key Words: World Journal of Diabetes; Correction

Core Tip: This is a correction to the article titled “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways (World J Diabetes 2024; 15 (3): 502-518 PMID: 38591083 DOI: 10.4239/wjd.v15.i3.502”). Following publication, it was identified that Figure 2 contained an error due to a typesetting issue. As the corresponding author, I am submitting a corrected figure to ensure the accuracy of the information provided in this article. This correction does not impact the conclusions of the manuscript.

CORRECTION

I am writing to formally report an image duplication issue identified in the article[1], titled “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”, which was published in the World Journal of Diabetes.

We have identified an error in original Figure 2, where the images for the control and high-dose Jianpi Gushen Huayu Decoction (JPGSH) groups were inadvertently duplicated. We will correct this error in the article.

In response to the journal’s request for editable figure files, we uploaded a PowerPoint file in which the control and JPGSH images were inadvertently duplicated. The accompanying Word document, however, remained correct. The duplication was subsequently carried over into the proof version during the typesetting process, and we unfortunately failed to identify the error during our review. As a result, the article was published with the duplicated image.

We sincerely apologize for this oversight and any inconvenience that it may have caused. In response, we have now prepared a corrected version of this figure (Figure 1), along with a formal Correction notice.

Figure 1 Pathological changes in the kidneys are improved following Jianpi Gushen Huayu Decoction administration. A: Hematoxylin and eosin staining; B: Kidney damage score; C: Periodic acid Schiff staining; D: Glomerulosclerosis index. Magnification, × 100. ^bP < 0.01 as compared to the control group; ^cP < 0.05 as compared to the model group; ^dP < 0.01 as compared to the model group. JPGSL: Low-dose Jianpi Gushen Huayu Decoction; JPGSM: Medium-dose Jianpi Gushen Huayu Decoction; JPGSH: High-dose Jianpi Gushen Huayu Decoction; IRBE: Irbesartan.

Thank you for your attention to this matter. We remain available to provide any further information or to assist with any additional steps as required.